Correlation Between Neuropace and LivaNova PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and LivaNova PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and LivaNova PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and LivaNova PLC, you can compare the effects of market volatilities on Neuropace and LivaNova PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of LivaNova PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and LivaNova PLC.

Diversification Opportunities for Neuropace and LivaNova PLC

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Neuropace and LivaNova is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and LivaNova PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LivaNova PLC and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with LivaNova PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LivaNova PLC has no effect on the direction of Neuropace i.e., Neuropace and LivaNova PLC go up and down completely randomly.

Pair Corralation between Neuropace and LivaNova PLC

Given the investment horizon of 90 days Neuropace is expected to generate 1.4 times more return on investment than LivaNova PLC. However, Neuropace is 1.4 times more volatile than LivaNova PLC. It trades about 0.06 of its potential returns per unit of risk. LivaNova PLC is currently generating about -0.08 per unit of risk. If you would invest  1,087  in Neuropace on December 30, 2024 and sell it today you would earn a total of  98.00  from holding Neuropace or generate 9.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  LivaNova PLC

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
LivaNova PLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days LivaNova PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Neuropace and LivaNova PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and LivaNova PLC

The main advantage of trading using opposite Neuropace and LivaNova PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, LivaNova PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LivaNova PLC will offset losses from the drop in LivaNova PLC's long position.
The idea behind Neuropace and LivaNova PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios